5-sulfanylindolin-2-one 、 4-甲基吲哚酮 、 氯磺酸 以provided 4.55 g of 5-chlorosulfonyl-4-methyloxindole (86.5% Y, 95% isomeric purity by 1H-NMR, in d6-acetone) which的产率得到5-chlorosulfonyl-4-methyloxindole
参考文献:
名称:
Compositions and Methods for Treatment of Neurodegenerative Disease
Compositions and methods for treatment of neurodegenerative disease
申请人:Zack Donald J.
公开号:US09162981B2
公开(公告)日:2015-10-20
Compounds, compositions, kits and methods for treating conditions related to neurodegeneration or ocular disease, are disclosed.
本发明揭示了用于治疗与神经退行性疾病或眼部疾病相关的条件的化合物、组合物、套装和方法。
COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASE
申请人:The Johns Hopkins University
公开号:EP2550263A2
公开(公告)日:2013-01-30
US9162981B2
申请人:——
公开号:US9162981B2
公开(公告)日:2015-10-20
US9539239B1
申请人:——
公开号:US9539239B1
公开(公告)日:2017-01-10
[EN] COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASE<br/>[FR] COMPOSITIONS ET MÉTHODES DE TRAITEMENT D'UNE MALADIE NEURODÉGÉNÉRATIVE
申请人:UNIV JOHNS HOPKINS
公开号:WO2011119777A2
公开(公告)日:2011-09-29
Compounds, compositions, kits and methods for treating conditions related to neurodegeneration or ocular disease, are disclosed.